Stem cell factor: Laboratory and clinical aspects

Blood Reviews

Volumn 15, Issue 4, 2001, Pages 191-197

  Smith, M A ^a   Court, E L ^a   Smith, J G ^b  

^a UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^b ROYAL UNITED HOSPITALS BATH NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Dendritic cells; Haemopoietic stem cells; Kit; Signal transduction; Stem cell factor; STI571

Indexed keywords

CYTOKINE; STEM CELL FACTOR;

ACUTE MYELOBLASTIC LEUKEMIA; APOPTOSIS; CELL GROWTH; CELL PROLIFERATION; DENDRITIC CELL; HEMATOPOIETIC STEM CELL; HUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0035735828     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1054/blre.2001.0167     Document Type: Article

References (73)

1. Stem cell factor and hematopoiesis
2. Stem cell factor: Biology and relevance to clinical practice
3. Kit signal transduction
4. The hematopoietic growth factor KL is encoded by the SI locus and is the ligand of the c-kit receptor, the gene product of the W locus
5. Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms
6. Membrane bound steel factor induces more persistant tyrosine kinase activation and longer life span of c-kit gene-encoded protein than its soluble form
7. Steel-Dickie mutation encodes a c-kit ligand lacking transmembrane and cytoplasmic domains
8. Soluble stem cell factor in human serum
9. SCF IL-1β, IL-Ira and GM-CSF in the bone marrow and serum of normal individuals and of AML and CML patients
10. Measurement of KIT ligand/stem cell factor: Clinical and biochemical significance
11. Cloning and structural analysis of the human c-kit gene
12. Downregulation of c-kit expression in human endothelial cells by iflammatory stimuli
13. IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells
14. Modulation of c-kit mRNA and protein by hemopoietic growth factors
15. Transforming growth factor-beta regulates c-kit mess- age stability and cell-surface protein expression in hematopoietic progenitors
16. Inhibition of stem cell factor-induced proliferation of primitive murine hematopoietic progenitor cells signaled through the 75-kilodalton tumor necrosis factor receptor: Regulation of c-kit and p53 expression
17. Interferon gamma downregulates stem cell factor and erythropoletin receptors but not insulin-like growth factor-I receptors in human erythroid colony-forming cells
18. Early signaling pathways activated by c-Kit in hematopoietic cells
19. Soluble receptors for cytokines and growth factors: Generation and biological function
20. Soluble cytokine receptors
21. Soluble kit receptor in human serum
22. Mechanism of kit ligand, phorbol ester, and calcium-induced down-regulation of c-kit receptors in mast cells
23. Identification and characterisation of a soluble c-kit receptor produced by human hematopoietic cell lines
24. Soluble c-kit receptor blocks stem cell factor bioactivity in vitro
25. Serum soluble c-kit receptor and expression of c-kit protein and mRNA in acute myeloid leukaemia
26. Serum markers of graft-versus-host disease after bone marrow transplantation
27. Stem cell factor, the JAK-STAT pathway and signal transduction
28. Kit signaling through PI 3-kinase and Src kinase pathways: An essential role for Rac1 and JNK activation in mast cell proliferation
29. Lck associates with and is activated by Kit in a small cell lung cancer cell line: Inhibition of SCF-mediated growth by Src family kinase inhibitor PPI
30. Stat1 associates with c-kit and is activated in response to stem cell factor
31. STAT protein recruitment and activation in c-Kit deletion mutants
32. Steel factor induces serine phosphorylation of Stat3 in human growth factor-dependent myeloid cell lines
33. Phosphatidylinositol 3-kinase and Ca2+ influx dependence for ligand-stimulated internalisation of the c-kit receptor
34. Protection from apoptosis by Steel factor but not interleukin-3 is reversed through blockade of calcium influx
35. Differential stimulation of c-kit mutants by membrane-bound and soluble Steel Factor correlates with leukemic potential
36. Stem cell factor as a survival and growth factor in normal and malignant haemopoiesis
37. Haemopoietic growth factors, the cell cycle of acute myeloblastic leukaemia progenitors and sensitivity to cytosine arabinoside
38. Kinetic characteristics of de novo and secondary AML cells influence their response to haemopoietic growth factor (HGF) priming and correlate with clinical outcome
39. Maintenance of high levels of pluripotent hematpoietic stem cells in vitro: Effect of stromal cells and c-Kit ligand
40. Mcl-1 is a common target of stem cell factor and interleukin-5 for apoptosis prevention activity via MEK/MAPK and PI-3K/Akt pathways
41. Stem cell factor/c-kit up regulates cyclinD3 and promotes cell cycle progression via the phosphoinositide 3-Kinase/p70 S6 kinase pathway in spermatogonia
42. Induction of the erythropoietin receptor gene and acquisition of responsiveness to erythropoietin by stem cell factor in HML/SE, a human leukemic cell line
43. A novel mechanism of cooperation between c-Kit and erythropoietin receptor
44. Fetal anemia and apoptosis of red cell progenitors in Stat 5a-/-5b-/-mice: A direct role for Stat in Bcl-X9L) induction
45. GATA-1 and erythropoietin cooperate to promote erythroid cell survival by regulating bcl-xL expression
46. Stem cell factor inhibits erythroid defferentiation by modulating the activity of G1-cyclin-dependent kinase complexes: A role for p27 in erythroid differentiation coupled G1 arrest
47. Stem cell factor protects c-kit+ human erythroid cells from apoptosis
48. The kit receptor promotes cell survival via activation of PI 3-kinase and subsequent Akt-mediated phosphorylation of Bad on Ser 136
49. Unraveling distinct intracellular signals that promote survival and proliferation: Study of erythropoietin, stem cell factor and constitutive signaling in leukemia cells
50. Differential expression of Bcl-3 homologs in human CD34+ hematopoietic progenitor cells induced to differentiate into erythroid or granulocytic cells
51. Stem cell factor prevents Fas-mediated apoptosis of human erythroid precursor cells with Src-family kinase dependency
52. Cross-talk between α4β1/α5β1 and c-Kit results in opposing effect on growth and survival of hemopoietic cells vai the activation of focal adhesion kinase, mitogen-activated protein kinase and Akt signaling pathways
53. Imhof BA. MHC class II and c-kit expression allows rapid enrichment of T-cell progenitors from total bone marrow cells
54. Stem cell factor and IL-2 act synergistically in inducing intraepithelial lymphocyte proliferation and cytokine production: Upregulation of the IL-2 receptor gamma-chain and signalling via JAK-3
55. Stem cell factor induces phosphatidylinositol 3′-kinase-dependent Lyn/Tec/Dok-1 complex formation in hematopoietic cells
56. C-kit ligand stimulates tyrosine phosphorylation of a similar pattern of phosphotyrosyl proteins in primary primitive normal hematopoietic progenitors that are constitutively phosphorylated in comparable primitive progenitors in chronic phase chronic myelogenous leukemia
57. Tyrosine phosphorylation of p62(Dok) induced by cell migration
58. STAT3 activation is required for Asp816 mutant c-Kit induced tumorigenicity
59. P13 kinase mediates transformation of hematopoletic cells by the V816 c-kit mutant
60. C-kit mutations in core binding factor leukemais
61. Rescue of haemopoiesis by a combination of growth factors including stem cell factor
62. Combination of stem cell factor and granulocyte colony-stimulating factor mobilises the highest number of primitive haemopoietic progenitors as shown by pre-colony-forming unit (pre-CFU) assay
63. G-CSF lead to the synergistic induction of proliferation and gene expression through complementary signaling pathways
64. Culture requirements for induction of dendritic cell differentiation in acute myeloid leukemia
65. The generation of dendritic-like cells with increased allostimulatory function from acute myeloid leukemia cells of various FAB subclasses
66. Cytokine driven differentiation of blasts from patients with acute myelogenous and lymphoblastic leukemia into dendritic cells
67. Effects of a selective inhibitor of the Ab1 tyrosine kinase on the growth of Bcr-Ab1 positive cells
68. Inhibition of c-kit receptor tyrosine kinase activity by STI 571
69. Ab1 protein tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet deruived growth factor receptors
70. The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in human myeloid leukemai cell line and acute myeloid leukemia cell blasts
71. The reliability and specificity of c-kit for the diagnosis of acyte myeloid leukaemias and undifferentiated leukaemias
72. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia
73. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies